Compare ALLR & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLR | GAUZ |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 22.5M |
| IPO Year | N/A | 2024 |
| Metric | ALLR | GAUZ |
|---|---|---|
| Price | $0.90 | $0.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $9.50 | ★ $11.50 |
| AVG Volume (30 Days) | 177.2K | ★ 268.6K |
| Earning Date | 03-30-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $96,810,000.00 |
| Revenue This Year | N/A | $22.59 |
| Revenue Next Year | N/A | $59.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.87 |
| 52 Week Low | $0.61 | $0.77 |
| 52 Week High | $2.35 | $12.13 |
| Indicator | ALLR | GAUZ |
|---|---|---|
| Relative Strength Index (RSI) | 37.88 | 39.36 |
| Support Level | $0.80 | $0.77 |
| Resistance Level | $1.00 | $1.10 |
| Average True Range (ATR) | 0.08 | 0.19 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 26.48 | 1.53 |
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.